Oral Communication and Rising Star Sessions

WBC 2026

Oral Communication and Rising Star Sessions

Browse the accepted poster abstracts and use the legend below to understand the poster numbering system.

Poster Numbering

Legend

A Day + Poster Area
B Session
C Poster Number
D1+2P1.01.01
Day 1 and Day 2, Poster Area 1, Session 01 and Poster Nr 01
Scientific Programme

Abstract List

×
Search :
#IDPresenterABCSessionTitle
143837_210Lidia PereaD1+2P30101Oral & Rising StarsAn exploratory sputum DNA methylation analysis in patients with bronchiectasis
243645_88Tihomir RubilD1+2P30102Oral & Rising StarsRestoring near-normal F508del-CFTR function: a cell-permeable nanobody synergizes with CFTR modulators in primary airway epithelial cells from patients with cystic fibrosis
343923_283Ezequiel BaranD1+2P30103Oral & Rising StarsBronchiectasis in South America: Demographics, Clinical Characteristics and Comparison with the EMBARC European Registry
443721_103Zhongbo ChenD1+2P30104Oral & Rising StarsBronchoalveolar lavage with N-acetylcysteine for acute exacerbations of bronchiectasis (BALANCE): a multicentre, randomised controlled trial
543838_211Chloe HughesD1+2P30105Oral & Rising StarsCharacterising systemic inflammation in patients with bronchiectasis: data from the EMBARC BRIDGE study
643752_127Ayako ShiozawaD1+2P30106Oral & Rising StarsEarly Mycobacterium abscessus Infection Drives Staged Epithelial Remodeling in Small Airways
743919_280Christina ThorntonD1+2P30107Oral & Rising StarsEpidemiology and Outcomes of Bronchiectasis in Alberta, Canada: A 15-Year Population-Based Study
843858_230Eric HouptD1+2P30108Oral & Rising StarsMAC diversity within patients over time and between patients and their environment
943780_161Ruth Maria UrbantatD1+2P30109Oral & Rising StarsOptimizing Conditional Cell Reprogramming for Enhanced Diagnostics and Therapeutic Screening in Primary Ciliary Dyskinesia
1043836_209Isabell PinkD1+2P30110Oral & Rising StarsSex differences in bronchiectasis – Data from the German Bronchiectasis Registry PROGNOSIS
1144065_424Fiona MosgroveD1+2P30111Oral & Rising StarsSputum microbiology in bronchiectasis and association with clinical outcomes: Data from the EMBARC registry
1243496_68Burkhard TümmlerD1+2P30112Oral & Rising StarsSubnormal CFTR activity in nasal potential difference of adults with idiopathic bronchiectasis
1343641_84Jayanth Kumar NarayanaD1+2P30113Oral & Rising StarsTwo Dimensions of Pseudomonas: How Abundotypes and Interactotypes explain inter-Individual heterogeneity in P. aeruginosa Bronchiectasis
1444218_507Martina SantambrogioD1+2P30114Oral & Rising StarsAn Italian, Multicenter, Pragmatic, Randomized, Controlled Trial Assessing the Efficacy and Safety of Nocturnal Humidification Therapy in Patients With Bronchiectasis: the AIRVO-BX Study
1543935_305Anthony De SoyzaD1+2P30115Oral & Rising StarsEfficacy and Safety of Itepekimab in Patients with Non-Cystic Fibrosis Bronchiectasis
1643810_187Julia KoenigD1+2P30116Oral & Rising StarsImproving ciliary function in DNAI1-deficient respiratory cells by mRNA therapy
1743865_237Rabindra TirouvanziamD1+2P30117Oral & Rising StarsIn vitro neutrophil migration into non-CF bronchiectasis sputum imprints a dysfunctional phenotype identical to in vivo
1843910_273Rachel ThomsonD1+2P30118Oral & Rising StarsPhase 3b ENCORE study of amikacin liposome inhalation suspension in new occurrence of Mycobacterium avium complex lung infection
1943707_95Shen Xi-YueD1+2P30119Oral & Rising StarsRedefining Cystic Fibrosis in Chinese Patients with Bronchiectasis
2043868_239Cuixia PanD1+2P30120Oral & Rising StarsSputum Multi-omics Integration Identifies Three Mechanistically Distinct Endotypes with Differential Exacerbation Risk in Bronchiectasis
We use cookies to ensure that we give you the best experience on our website.We use cookies to improve analyze its performance. You can authorize or block the cookies by clicking the checkbox on the right side of each single cookie. See our cookies policy.
Google Analytics, I accept: